Collegium Pharmaceutical, Inc. - Common Stock (COLL)

Collegium Pharmaceutical is a biotechnology company that focuses on developing innovative treatments for pain management and related conditions

The company specializes in formulating and bringing to market unique drug delivery systems and therapies that aim to enhance patient outcomes while addressing issues like opioid misuse and dependence. By leveraging advanced technology and scientific research, Collegium strives to provide healthcare professionals and patients with effective and safer alternatives for managing acute and chronic pain, contributing to improving overall quality of life.